ARK Genomic Revolution ETF vs Jabil Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Jabil Inc trades at $365.99 (market cap $37.37B). The key difference: Jabil Inc pays a 0.09% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Jabil Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | JBL | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $385.50 |
52-Week Low | $24.02 | $192.49 |
Market Cap | — | $37.37B |
Enterprise Value | — | $39.90B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →